Barclays Maintains Overweight on Merck & Co, Raises Price Target to $180
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Barclays analyst Emily Field maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $150 to $180.
Barclays analyst Emily Field maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $150 to $180.